SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 16.51 |
Enterprise Value ($M) | 15.93 |
Book Value ($M) | 2.26 |
Book Value / Share | 0.33 |
Price / Book | 7.29 |
NCAV ($M) | 0.17 |
NCAV / Share | 0.02 |
Price / NCAV | 96.14 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.67 |
Return on Assets (ROA) | -0.78 |
Return on Equity (ROE) | -1.05 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.09 |
Current Ratio | 1.09 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.07 |
Assets | 4.16 |
Liabilities | 1.90 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -7.01 |
Net Income | -6.17 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -4.89 |
Cash from Investing | 0.00 |
Cash from Financing | 0.59 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Stonepine Capital Management, LLC | 9.90 | ||
13D | Velan Capital Master Fund LP | 9.99 | ||
13G/A | Satterfield Thomas A Jr | 0.00 | ||
13D/A | Nijhawan Pardeep | 19.99 | 136.42 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,673 | 11,384 | 23.48 | |
621 | 10,498 | 5.92 | |
808 | 20,104 | 4.02 | |
2,704 | 36,326 | 7.44 | |
14,453 | 74,769 | 19.33 | |
(click for more detail) |
Similar Companies | |
---|---|
DTIL – Precision BioSciences, Inc. | DWTX – Dogwood Therapeutics, Inc. |
DYAI – Dyadic International, Inc. | ELDN – Eledon Pharmaceuticals, Inc. |
ELTX – Elicio Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io